Bio*One Capital Pte Ltd, a subsidiary of EDB Investments (EDBI), is dedicated to investments in the Biomedical Sciences industry. Biomedical Sciences (BMS) is a key economic driver and an important pillar of Singapore's diverse economy. With over US$790 million currently under management, Bio*One Capital is actively investing our fourth fund, Biomedical Sciences Investments Fund (BMSIF). Key sectors of interest are therapeutics and therapeutics services, medical technology and healthcare services.

 

We back fast-growing companies in the BMS sector targeting excellent market opportunities with a clear exit strategy. We focus on companies that have the potential to grow rapidly in value, and through our investment, become well positioned to tap into the fast growing Asian market to fuel the companies’ growth. We are more than a financial investor. Bio*One invests in companies where we believe that we can enhance the value of the company’s operation, for example, through establishment of sustainable R&D, and/or manufacturing and/or business operations in Singapore. Bio*One currently invests in late-stage private and public companies, and holds a portfolio of more than 50 companies worldwide.

   
 
 
Contact Us | © 2008 EDBI. All rights reserved.